JP2021503451A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021503451A5 JP2021503451A5 JP2020526523A JP2020526523A JP2021503451A5 JP 2021503451 A5 JP2021503451 A5 JP 2021503451A5 JP 2020526523 A JP2020526523 A JP 2020526523A JP 2020526523 A JP2020526523 A JP 2020526523A JP 2021503451 A5 JP2021503451 A5 JP 2021503451A5
- Authority
- JP
- Japan
- Prior art keywords
- administration
- pharmaceutical composition
- pharmaceutically acceptable
- composition according
- crystal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BHUUZZOWKNSCSC-BLAHKUQESA-N CC(C)OC(CCC/C=C\C[C@@H]([C@H](C[C@H]1[O]#C)O)[C@H]1/C=C/C(COc1ccccc1)(F)F)=O Chemical compound CC(C)OC(CCC/C=C\C[C@@H]([C@H](C[C@H]1[O]#C)O)[C@H]1/C=C/C(COc1ccccc1)(F)F)=O BHUUZZOWKNSCSC-BLAHKUQESA-N 0.000 description 1
- IAVUPMFITXYVAF-UHFFFAOYSA-O CC[NH2+]C(CC1C)c(cc([s]2)S(N)(=O)=O)c2S1(=O)=O Chemical compound CC[NH2+]C(CC1C)c(cc([s]2)S(N)(=O)=O)c2S1(=O)=O IAVUPMFITXYVAF-UHFFFAOYSA-O 0.000 description 1
- 0 CN(CC(O)=O)C([*+])=N Chemical compound CN(CC(O)=O)C([*+])=N 0.000 description 1
- JVFUZOJFSADMTB-SJXJOUCVSA-N O=CCN/C=C/CCC[C@H](C1)[C@]11S=SCCC1 Chemical compound O=CCN/C=C/CCC[C@H](C1)[C@]11S=SCCC1 JVFUZOJFSADMTB-SJXJOUCVSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201741041231 | 2017-11-17 | ||
| IN201741041231 | 2017-11-17 | ||
| IN201841032406 | 2018-08-29 | ||
| IN201841032406 | 2018-08-29 | ||
| PCT/IB2018/058848 WO2019097381A1 (en) | 2017-11-17 | 2018-11-10 | Compounds, compositions and methods for treatment of eye disorders and skin diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021503451A JP2021503451A (ja) | 2021-02-12 |
| JP2021503451A5 true JP2021503451A5 (https=) | 2021-11-04 |
| JP7038437B2 JP7038437B2 (ja) | 2022-03-18 |
Family
ID=66538944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020526523A Expired - Fee Related JP7038437B2 (ja) | 2017-11-17 | 2018-11-10 | 眼障害及び皮膚疾患の処置のための化合物、組成物、及び方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11186561B2 (https=) |
| EP (1) | EP3709982A4 (https=) |
| JP (1) | JP7038437B2 (https=) |
| KR (1) | KR102405239B1 (https=) |
| CN (1) | CN111315369A (https=) |
| AU (1) | AU2018369853B2 (https=) |
| BR (1) | BR112020009364A2 (https=) |
| CA (1) | CA3081482A1 (https=) |
| IL (1) | IL274233B2 (https=) |
| MX (1) | MX392359B (https=) |
| RU (1) | RU2020119228A (https=) |
| SG (1) | SG11202004078YA (https=) |
| WO (1) | WO2019097381A1 (https=) |
| ZA (1) | ZA202002075B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021001645A (es) * | 2018-08-29 | 2021-05-12 | Cellix Bio Private Ltd | Metodos y composiciones oftalmicas para el tratamiento de trastornos del ojo y enfermedades de la piel. |
| JP2022516796A (ja) * | 2019-01-12 | 2022-03-02 | セリックス バイオ プライヴェート リミテッド | 選択的αアドレナリン受容体作用薬又は抗コリン作動薬及びリポ酸の組合せ物並びにその使用 |
| CN116850182B (zh) * | 2021-04-30 | 2025-11-21 | 远大医药（中国）有限公司 | 用于治疗近视的方法和药物组合物 |
| KR20260012787A (ko) | 2023-05-24 | 2026-01-27 | 아이 하스피틀, 웬조우 메디칼 유니버시티 | 근시를 효과적으로 지연 및 치료하는 약학 조성물 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR4512E (fr) * | 1904-07-12 | 1905-08-26 | Georges Albert Simon Weill | Genre de lyre de construction économique pour suspensions de lampes |
| FR4512M (https=) * | 1965-05-18 | 1966-10-17 | ||
| US5080646A (en) | 1988-10-03 | 1992-01-14 | Alza Corporation | Membrane for electrotransport transdermal drug delivery |
| IL113459A (en) | 1995-04-23 | 2000-07-16 | Electromagnetic Bracing System | Electrophoretic cuff apparatus |
| US6239180B1 (en) | 1995-11-08 | 2001-05-29 | The Regents Of The University Of California | Transdermal therapeutic device and method with capsaicin and capsaicin analogs |
| CN1152673C (zh) | 1997-10-28 | 2004-06-09 | 坂东化学株式会社 | 皮肤贴附药片及其基片的制造方法 |
| US6103275A (en) | 1998-06-10 | 2000-08-15 | Nitric Oxide Solutions | Systems and methods for topical treatment with nitric oxide |
| DE19827732A1 (de) | 1998-06-22 | 1999-12-23 | Rottapharm Bv | Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie |
| US6312716B1 (en) | 1999-05-10 | 2001-11-06 | Peierce Management Llc | Patch and method for transdermal delivery of bupropion base |
| US6974588B1 (en) | 1999-12-07 | 2005-12-13 | Elan Pharma International Limited | Transdermal patch for delivering volatile liquid drugs |
| FR2832637B1 (fr) * | 2001-06-07 | 2004-07-30 | Lefaix Marie Therese Droy | Utilisation d'un antioxydant pour la fabrication d'un medicament destine au traitement des affections oculaires de surface |
| ITMI20030831A1 (it) * | 2003-04-22 | 2004-10-23 | Laboratorio Chimico Int Spa | Sale basico dell'acido tiottico con la l-carnitina. |
| WO2007149313A1 (en) * | 2006-06-16 | 2007-12-27 | Indigene Pharmaceuticals Inc. | Metformin r-(+) lipoate as an antidiabetic agent for control of diabetic hyperglycemia and diabetic complications |
| GB0724558D0 (en) | 2007-12-15 | 2008-01-30 | Sharma Anant | Optical correction |
| WO2010125416A1 (en) * | 2009-04-27 | 2010-11-04 | Raouf Rekik | Drug delivery to the anterior and posterior segments of the eye |
| KR101586789B1 (ko) | 2012-12-28 | 2016-01-19 | 주식회사 종근당 | 양이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
| WO2014124141A1 (en) * | 2013-02-07 | 2014-08-14 | Mylari Banavara L | Metformin derivatives for treating diabetes |
| WO2015103577A1 (en) | 2014-01-06 | 2015-07-09 | Stealth Peptides International, Inc. | Methods and compositions for preventing or treating dominant optic atrophy |
| CN104387364B (zh) * | 2014-12-15 | 2016-11-16 | 南京工业大学 | L-鸟氨酸硫辛酸复合盐及其制备方法和应用 |
| MX386467B (es) * | 2016-10-04 | 2025-03-18 | Cellix Bio Private Ltd | Composiciones y métodos para el tratamiento de xerostomia (sequedad bucal) |
| SG11202004019SA (en) * | 2017-11-17 | 2020-05-28 | Cellix Bio Private Ltd | Compositions and methods for the treatment of eye disorders |
-
2018
- 2018-11-10 MX MX2020004667A patent/MX392359B/es unknown
- 2018-11-10 CN CN201880071268.0A patent/CN111315369A/zh active Pending
- 2018-11-10 KR KR1020207017163A patent/KR102405239B1/ko not_active Expired - Fee Related
- 2018-11-10 SG SG11202004078YA patent/SG11202004078YA/en unknown
- 2018-11-10 IL IL274233A patent/IL274233B2/en unknown
- 2018-11-10 WO PCT/IB2018/058848 patent/WO2019097381A1/en not_active Ceased
- 2018-11-10 RU RU2020119228A patent/RU2020119228A/ru unknown
- 2018-11-10 CA CA3081482A patent/CA3081482A1/en active Pending
- 2018-11-10 JP JP2020526523A patent/JP7038437B2/ja not_active Expired - Fee Related
- 2018-11-10 EP EP18879564.5A patent/EP3709982A4/en not_active Withdrawn
- 2018-11-10 BR BR112020009364-5A patent/BR112020009364A2/pt not_active IP Right Cessation
- 2018-11-10 AU AU2018369853A patent/AU2018369853B2/en not_active Ceased
-
2020
- 2020-05-04 ZA ZA2020/02075A patent/ZA202002075B/en unknown
- 2020-05-07 US US16/869,352 patent/US11186561B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021503451A5 (https=) | ||
| JP2022515197A5 (https=) | ||
| JP2021503449A5 (https=) | ||
| JP2014511892A5 (https=) | ||
| JP2021512098A5 (https=) | ||
| JP2020509022A5 (https=) | ||
| JP2016534063A5 (https=) | ||
| JP2018021046A5 (https=) | ||
| JP2016519165A5 (https=) | ||
| JP2005523922A5 (https=) | ||
| JP2020512337A5 (https=) | ||
| JP2019535723A5 (https=) | ||
| JP2013542261A5 (https=) | ||
| JP2012513416A5 (https=) | ||
| JP2020507589A5 (https=) | ||
| JP2020502047A5 (https=) | ||
| JP2015508092A5 (https=) | ||
| JP2018513832A5 (https=) | ||
| JP2016529235A5 (https=) | ||
| JP2016510768A5 (https=) | ||
| JP2010514733A5 (https=) | ||
| JP2009040767A5 (https=) | ||
| IL274233B1 (en) | Compounds, compositions and methods for treatment of eye disorders and skin diseases | |
| JP2019151627A5 (https=) | ||
| JP2017039714A5 (https=) |